Share on

Middle East and Africa Anti-neoplastic Agents Market Research Report – Segmented By Product Type, End User & Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) – Industry Size, Share, Trends & Growth Forecast (2022 to 2027)

Published: March, 2023
ID: 8051
Pages: 145
Formats: report pdf report excel report power bi report ppt

The size of the MEA Anti-neoplastic Agents Market is projected to be progressing at a sluggish rate between 2022 to 2027.

Anti-neoplastic Agents are the first line of treatment for cancer. A variety of antineoplastics are available in the market and many drugs are still in the clinical phase. Cancer is becoming a major cause of death all over the world.

Rising number of people being diagnosed with cancer and the demand for affordable treatments for the same are the major drivers driving the market growth. Due to the recent advancements in personalised medicines the market is expected to propel during the forecast period. However, the high manufacturing costs of anti-neoplastic agents is the major factor hampering the market growth.

The market for Anti-neoplastic Agents is broadly categorized into product type and end user. By product type the market is divided into personalised medicine, biological agents and chemotherapeutic agents. Chemotherapeutic agents account for a major share of the market revenue. By end user the market is segmented into hospitals, clinics, cancer rehabilitation centres and ambulatory surgical centres. Hospitals segment dominated a major share of the market revenue. On the basis of geography, the market is analysed under various regions namely Middle East and Africa .

Some of the major companies dominating the market, by their products and services include Aspen Global Inc., Bayer AG, Teva pharmaceutical Industries Ltd., Johnson & Johnson Pvt. Ltd., Merc & Co., Inc., Pfize Inc., Hoffmann-La Roche Ltd., Amgen Inc., Bristol-Myers Squibb Company, Baxter Healthcare Corporation, Boehringer Ingelheim GmbH, Accord Healthcare, Inc., Genentech, Inc., Lundbeck LLC and AbbVie Inc.

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample